Assessment of the Glycan-Binding Profile of Pseudomonas aeruginosa PAO1.
Pseudomonas aeruginosa
array
glycan
host-pathogen interactions
phagocytosis
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
17 08 2023
17 08 2023
Historique:
medline:
21
8
2023
pubmed:
20
7
2023
entrez:
20
7
2023
Statut:
ppublish
Résumé
Pseudomonas aeruginosa is an opportunistic pathogen that can establish acute and chronic infections in individuals who lack fully functional innate immunity. In particular, phagocytosis by neutrophils and macrophages is a key mechanism that modulates host control and clearance of P. aeruginosa. Individuals with neutropenia or cystic fibrosis are highly susceptible to P. aeruginosa infection, thus underscoring the importance of the host innate immune response. Cell-to-cell contact between host innate immune cells and the pathogen, a first step in phagocytic uptake, is facilitated by simple and complex glycan structures present at the host cell surface. We have previously shown that endogenous polyanionic N-linked glycans localized to the cell surface of phagocytes mediate the binding and subsequent phagocytosis of P. aeruginosa cells. However, the suite of glycans that P. aeruginosa cells bind to on host phagocytic cells remains poorly characterized. Here, we demonstrate, with the use of exogenous N-linked glycans and a glycan array, that P. aeruginosa PAO1 cells preferentially attach to a subset of glycans, including a bias toward monosaccharide versus more complex glycan structures. Consistent with these findings, we were able to competitively inhibit bacterial adherence and uptake by the addition of exogenous N-linked mono- and disaccharide glycans. We discuss our findings in the context of previous reports of P. aeruginosa glycan binding.
Identifiants
pubmed: 37470715
doi: 10.1128/spectrum.01667-23
pmc: PMC10434018
doi:
Substances chimiques
Polysaccharides
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0166723Commentaires et corrections
Type : UpdateOf
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Infect Immun. 2001 Sep;69(9):5243-8
pubmed: 11500392
Nature. 2003 Nov 20;426(6964):306-10
pubmed: 14628055
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3038-42
pubmed: 8464920
Antimicrob Agents Chemother. 1999 Dec;43(12):2877-80
pubmed: 10582875
Antimicrob Agents Chemother. 2000 Dec;44(12):3249-56
pubmed: 11083623
PLoS Pathog. 2011 Sep;7(9):e1002253
pubmed: 21949654
Arch Biochem Biophys. 1988 Jan;260(1):493-6
pubmed: 3124753
PLoS Pathog. 2012;8(4):e1002616
pubmed: 22496644
Nat Immunol. 2008 Jun;9(6):593-601
pubmed: 18490910
Clin Microbiol Rev. 2003 Oct;16(4):597-621
pubmed: 14557288
Mol Immunol. 2021 Mar;131:68-77
pubmed: 33358569
J Bacteriol. 2005 Jan;187(2):771-7
pubmed: 15629949
Infect Immun. 1994 Feb;62(2):596-605
pubmed: 8300217
Infect Immun. 1985 Nov;50(2):577-82
pubmed: 3932214
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8922-6
pubmed: 9671780
Infect Immun. 1992 Dec;60(12):5078-84
pubmed: 1452340
Clin Microbiol Rev. 2011 Jan;24(1):29-70
pubmed: 21233507
Sci Rep. 2018 May 30;8(1):8419
pubmed: 29849092
Infect Immun. 2018 Jul 23;86(8):
pubmed: 29844235
Annu Rev Microbiol. 1995;49:239-76
pubmed: 8561460
Langmuir. 2013 Apr 16;29(15):4823-9
pubmed: 23509956
Infect Immun. 2010 Mar;78(3):939-53
pubmed: 20008530
Rapid Commun Mass Spectrom. 2008 May;22(10):1579-86
pubmed: 18433086
Infect Immun. 2009 May;77(5):2065-75
pubmed: 19237519
Infect Immun. 2020 Apr 20;88(5):
pubmed: 32041787
J Proteome Res. 2017 Jan 6;16(1):156-169
pubmed: 27351377
Cell. 2006 Feb 24;124(4):783-801
pubmed: 16497588
Infect Immun. 1991 Feb;59(2):700-4
pubmed: 1670932
Infect Immun. 2013 Jun;81(6):2043-52
pubmed: 23529619
Methods Mol Biol. 2020;2132:257-266
pubmed: 32306333
Environ Microbiol. 2006 Jun;8(6):1095-104
pubmed: 16689730
Infect Immun. 2010 Jul;78(7):2937-45
pubmed: 20457788
J Bacteriol. 2003 Feb;185(3):1027-36
pubmed: 12533479
Infect Immun. 2009 Dec;77(12):5300-10
pubmed: 19805527
mBio. 2017 Jan 24;8(1):
pubmed: 28119471
J Infect Dis. 2014 Oct 15;210(8):1286-95
pubmed: 24755437
Nature. 2008 Dec 4;456(7222):648-52
pubmed: 18971931
Glycoconj J. 2001 Sep;18(9):709-13
pubmed: 12386456
Nat Rev Microbiol. 2018 Jul;16(7):440-452
pubmed: 29674747
Infect Immun. 1985 May;48(2):331-5
pubmed: 2985503
Glycobiology. 2017 Jan;27(1):3-49
pubmed: 27558841
J Bacteriol. 2000 Mar;182(5):1257-63
pubmed: 10671445
Glycobiology. 1999 Aug;9(8):757-64
pubmed: 10406841